PRISM MEDICO AND PHARMACY LTD.

Company Profile

PRISM MEDICO AND PHARMACY LTD. had its IPO on under the ticker symbol PRISMMEDI.

The company operates in the sector and industry. PRISM MEDICO AND PHARMACY LTD. has a staff strength of 0 employees.

Stock update

Shares of PRISM MEDICO AND PHARMACY LTD. opened at ₹27 at the start of the last trading session i.e. 2023-09-13.

The stocks traded within a range of ₹26.94 - ₹29.6, and closed at ₹27.

This is a -4.76% slip from the previous day's closing price.

A total volume of 18,390 shares were traded at the close of the day’s session.

In the last one week, shares of PRISM MEDICO AND PHARMACY LTD. have increased by +6.51%.

PRISM MEDICO AND PHARMACY LTD.'s Key Ratios

PRISM MEDICO AND PHARMACY LTD. has a market cap of ₹180.39 million, indicating a price to book ratio of 0.9444 and a price to sales ratio of 1.3931.

In the last 12-months PRISM MEDICO AND PHARMACY LTD.’s revenue was ₹0 with a gross profit of ₹2.79 million and an EBITDA of ₹0. The EBITDA ratio measures PRISM MEDICO AND PHARMACY LTD.'s overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, PRISM MEDICO AND PHARMACY LTD.’s operating margin was 0% while its return on assets stood at 0% with a return of equity of 0%.

In Q4, PRISM MEDICO AND PHARMACY LTD.’s quarterly earnings growth was a positive 0% while revenue growth was a positive 0%.

PRISM MEDICO AND PHARMACY LTD.’s PE and PEG Ratio

Forward PE

0

Trailing PE

0

PEG

Its diluted EPS in the last 12-months stands at ₹0 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into PRISM MEDICO AND PHARMACY LTD.’s profitability.

PRISM MEDICO AND PHARMACY LTD. stock is trading at a EV to sales ratio of 1.3862 and a EV to EBITDA ratio of -26.7758. Its price to sales ratio in the trailing 12-months stood at 1.3931.

PRISM MEDICO AND PHARMACY LTD. stock pays annual dividends of ₹ per share, indicating a yield of None and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

₹125.39 million

Total Liabilities

₹835000.00

Operating Cash Flow

₹0

Capital Expenditure

₹0

Dividend Payout Ratio

0%

PRISM MEDICO AND PHARMACY LTD. ended 2025 with ₹125.39 million in total assets and ₹0 in total liabilities. Its intangible assets were valued at ₹125.39 million while shareholder equity stood at ₹124.55 million.

PRISM MEDICO AND PHARMACY LTD. ended 2025 with ₹0 in deferred long-term liabilities, ₹835000.00 in other current liabilities, in common stock, ₹0 in retained earnings and ₹0 in goodwill. Its cash balance stood at ₹578000.00 and cash and short-term investments were ₹0. The company’s total short-term debt was ₹0 while long-term debt stood at ₹0.

PRISM MEDICO AND PHARMACY LTD.’s total current assets stands at ₹123.09 million while long-term investments were ₹0 and short-term investments were ₹0. Its net receivables were ₹48.48 million compared to accounts payable of ₹0 and inventory worth ₹67.71 million.

In 2025, PRISM MEDICO AND PHARMACY LTD.'s operating cash flow was ₹0 while its capital expenditure stood at ₹0.

Comparatively, PRISM MEDICO AND PHARMACY LTD. paid ₹0 in dividends in 2025.

Other key metrics

Current Trading Price

₹27

52-Week High

₹46.8

52-Week Low

₹6.53

Analyst Target Price

₹

PRISM MEDICO AND PHARMACY LTD. stock is currently trading at ₹27 per share. It touched a 52-week high of ₹46.8 and a 52-week low of ₹46.8. Analysts tracking the stock have a 12-month average target price of ₹.

Its 50-day moving average was ₹25.79 and 200-day moving average was ₹28.08 The short ratio stood at 0 indicating a short percent outstanding of 0%.

Around 0% of the company’s stock are held by insiders while 0% are held by institutions.